Biodegradable metal alloys
US-9863020-B2 · Jan 9, 2018 · US
US11696976B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11696976-B2 |
| Application number | US-201615750219-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 22, 2016 |
| Priority date | Aug 21, 2015 |
| Publication date | Jul 11, 2023 |
| Grant date | Jul 11, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to biodegradable, magnesium alloys, compositions and composites, methods for their preparation and applications for their use as implantable medical devices in load-bearing conditions. The magnesium alloys are composed of alloying elements selected from yttrium, calcium, zirconium, zinc, and strontium, with the remainder being magnesium and impurities due to production, and are prepared by melting together the elements and casting the resulting melted mixture. In certain embodiments, the methods of preparation include solution treatment and hot extrusion.
Opening claim text (preview).
The invention claimed is: 1. An orthopedic or craniofacial bone fixation component composed of an extruded biodegradable, magnesium alloy, consisting of: from 0.5 weight percent to 4.0 weight percent of yttrium; from greater than zero to 1.0 weight percent of calcium; from 1.0 weight percent to 6.0 weight percent of zinc; from greater than zero to 1.0 weight percent of zirconium; from 0.10 weight percent to 6.0 weight percent of strontium; and a balance of magnesium and impurities due to production, based on total weight of the alloy, wherein the orthopedic or craniofacial bone fixation component is selected from the group consisting of Kirschner wire, cerclage wire, intramedullary rod, and intramedullary pin, and wherein the extruded biodegradable, magnesium alloy has formed precipitates arranged in a long period stacking order. 2. An orthopedic or craniofacial bone fixation component composed of an extruded biodegradable, magnesium alloy, consisting of: from 1.0 weight percent to 6.0 weight percent of zinc; from greater than zero to 1.0 weight percent of zirconium; optionally from greater than zero to 6.0 weight percent of strontium; optionally from 1.0 weight percent to 9.0 weight percent aluminum; optionally from 0.1 weight percent to 1.0 weight percent of manganese; optionally from 0.25 weight percent to 1.0 weight percent of silver; optionally from 0.1 weight percent to 1.0 weight percent of cerium; and a balance of magnesium and impurities due to production, based on total weight of the alloy, wherein the orthopedic or craniofacial bone fixation component is selected from the group consisting of Kirschner wire, cerclage wire, intramedullary rod and intramedullary pin, and wherein the extruded biodegradable, magnesium alloy has formed precipitates arranged in a long period stacking order.
Materials at least partially resorbable by the body · CPC title
with zinc or cadmium as the next major constituent · CPC title
Metals or alloys · CPC title
for reconstruction of bones; weight-bearing implants · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.